鲁南制药集团与国控山东签署战略合作协议

Group 1 - The core viewpoint of the article is the strategic cooperation between Lunan Pharmaceutical Group and China National Pharmaceutical Group Shandong, focusing on collaboration in the pharmaceutical industry chain, market integration, digital supply chain optimization, and service enhancement [1][3] Group 2 - Lunan Pharmaceutical Group emphasizes the importance of building a collaborative development mechanism in the pharmaceutical industry during its transition to high-quality development [3] - The strategic signing marks a commitment to four core pillars: strategic collaboration, innovation-driven, value sharing, and sustainable development, with plans for comprehensive cooperation in market planning, digital services, efficiency mechanisms, and social responsibility [3] - Lunan Pharmaceutical Group aims to leverage its product development advantages and integrate deeply with China National Pharmaceutical Group Shandong's channel network to enhance drug accessibility and service quality [3] - China National Pharmaceutical Group Shandong highlights its network advantages and digital supply chain capabilities, forming a complementary strategic relationship with Lunan Pharmaceutical Group [3] - Future collaboration will focus on breaking traditional business cooperation limitations, enhancing terminal development, academic promotion, party building, and talent cultivation [3]